Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$8.47
+2.23%
Mkt Cap $521.05M
Analyst Ratings
Buy
3
Hold
4
Sell
0
Price Target (20 analysts)
$5.83
Range $3.50 – $7.00
Implied Upside
-31.2%
Consensus $5.83 vs current $8.47
NASDAQ·Healthcare·Biotechnology
$8.47
+2.23%
Mkt Cap $521.05M
Buy
3
Hold
4
Sell
0
Price Target (20 analysts)
$5.83
Range $3.50 – $7.00
-31.2%
Consensus $5.83 vs current $8.47